xaluritamig

Trials studying xaluritamig

• phase1Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancerrecruitingn=40
• phase2LuX: Xaluritamig in Participants With Metastatic Castrate Resistant Prostate Cancer and Suboptimal Response to Lutetium 177 Vipivotide Tetraxetannot yet recruitingn=30
• phase3A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancerrecruitingn=750
• phase1Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)recruitingn=50
• phase3Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)recruitingn=675
• phase1Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancerrecruitingn=60
• phase1Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Canceractive not recruitingn=50
• phase1Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancerrecruitingn=40